cr completed with si's, page-9

peaceAKKI/others: To me this is worse than just "disappointing"!! This clearly PUNISHES loyal longterm holders of PYC.
But to me it is also a worry - perhaps all these big pharmas trying out PYC peptides are not seeing what they like to see in the results and hence none of them is coming "on board" in a big way?? And therefore, PYC HAS to entice so called "sophisticated" ones with a really LOW offer to put money into this that may leave with a profit promptly again. Those "sophisticated" ones are often not loyal but just short-term profit takers. (IMHO).
Moreover, those many PYCOA's out now will put a damper on any really significant sp appreciation in the future as well (IMHO).
And agree with you peaceAKKI: NOTHING is really "remaining on track" thus far!! Clearly PYC has overpromised resp. grossly underdelivered.
Not a happpy shareholder here!
wasa